The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ischemia Reperfusion Injury Market Research Report 2025
Synopsis
Reperfusion injury or reperfusion insult, sometimes called ischemia-reperfusion injury (IRI) or reoxygenation injury, is the tissue damage caused when blood supply returns to tissue (re- + perfusion) after a period of ischemia or lack of oxygen (anoxia or hypoxia). The absence of oxygen and nutrients from blood during the ischemic period creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative stress rather than (or along with) restoration of normal function.
The global Ischemia Reperfusion Injury market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Global Ischemia Reperfusion Injury key players include Angion Biomedica, Catalyst Biosciences, Ischemix Inc, etc.
North America is the largest market, with a share about 50%, followed by Europe, and Japan, both have a share over 20 percent.
In terms of product, Phase 2 is the largest segment, with a share about 40%. And in terms of application, the largest application is Kidney Injury, followed by Heart Injury, Intestine Injury, etc.
This report aims to provide a comprehensive presentation of the global market for Ischemia Reperfusion Injury, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ischemia Reperfusion Injury.
Report Scope
The Ischemia Reperfusion Injury market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ischemia Reperfusion Injury market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ischemia Reperfusion Injury companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Angion Biomedica
Catalyst Biosciences
Ischemix Inc
Opsona Therapeutics
Pharming
TheraSource
Bolder Biotechnology
Corline Biomedical
Mifcortx
Balmes Transplantation
NovelMed Therapeutics
Hope Pharmaceuticals
Omeros Corp
Prothix
SBI Pharmaceuticals
Segment by Type
Phase 1
Phase 2
Preclinical
Segment by Application
Heart Injury
Kidney Injury
Intestine Injury
Other Injury
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ischemia Reperfusion Injury companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Reperfusion injury or reperfusion insult, sometimes called ischemia-reperfusion injury (IRI) or reoxygenation injury, is the tissue damage caused when blood supply returns to tissue (re- + perfusion) after a period of ischemia or lack of oxygen (anoxia or hypoxia). The absence of oxygen and nutrients from blood during the ischemic period creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative stress rather than (or along with) restoration of normal function.
The global Ischemia Reperfusion Injury market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Global Ischemia Reperfusion Injury key players include Angion Biomedica, Catalyst Biosciences, Ischemix Inc, etc.
North America is the largest market, with a share about 50%, followed by Europe, and Japan, both have a share over 20 percent.
In terms of product, Phase 2 is the largest segment, with a share about 40%. And in terms of application, the largest application is Kidney Injury, followed by Heart Injury, Intestine Injury, etc.
This report aims to provide a comprehensive presentation of the global market for Ischemia Reperfusion Injury, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ischemia Reperfusion Injury.
Report Scope
The Ischemia Reperfusion Injury market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ischemia Reperfusion Injury market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ischemia Reperfusion Injury companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Angion Biomedica
Catalyst Biosciences
Ischemix Inc
Opsona Therapeutics
Pharming
TheraSource
Bolder Biotechnology
Corline Biomedical
Mifcortx
Balmes Transplantation
NovelMed Therapeutics
Hope Pharmaceuticals
Omeros Corp
Prothix
SBI Pharmaceuticals
Segment by Type
Phase 1
Phase 2
Preclinical
Segment by Application
Heart Injury
Kidney Injury
Intestine Injury
Other Injury
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ischemia Reperfusion Injury companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ischemia Reperfusion Injury Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Phase 1
1.2.3 Phase 2
1.2.4 Preclinical
1.3 Market by Application
1.3.1 Global Ischemia Reperfusion Injury Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Heart Injury
1.3.3 Kidney Injury
1.3.4 Intestine Injury
1.3.5 Other Injury
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ischemia Reperfusion Injury Market Perspective (2019-2030)
2.2 Ischemia Reperfusion Injury Growth Trends by Region
2.2.1 Global Ischemia Reperfusion Injury Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Ischemia Reperfusion Injury Historic Market Size by Region (2019-2024)
2.2.3 Ischemia Reperfusion Injury Forecasted Market Size by Region (2025-2030)
2.3 Ischemia Reperfusion Injury Market Dynamics
2.3.1 Ischemia Reperfusion Injury Industry Trends
2.3.2 Ischemia Reperfusion Injury Market Drivers
2.3.3 Ischemia Reperfusion Injury Market Challenges
2.3.4 Ischemia Reperfusion Injury Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ischemia Reperfusion Injury Players by Revenue
3.1.1 Global Top Ischemia Reperfusion Injury Players by Revenue (2019-2024)
3.1.2 Global Ischemia Reperfusion Injury Revenue Market Share by Players (2019-2024)
3.2 Global Ischemia Reperfusion Injury Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ischemia Reperfusion Injury Revenue
3.4 Global Ischemia Reperfusion Injury Market Concentration Ratio
3.4.1 Global Ischemia Reperfusion Injury Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ischemia Reperfusion Injury Revenue in 2023
3.5 Ischemia Reperfusion Injury Key Players Head office and Area Served
3.6 Key Players Ischemia Reperfusion Injury Product Solution and Service
3.7 Date of Enter into Ischemia Reperfusion Injury Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ischemia Reperfusion Injury Breakdown Data by Type
4.1 Global Ischemia Reperfusion Injury Historic Market Size by Type (2019-2024)
4.2 Global Ischemia Reperfusion Injury Forecasted Market Size by Type (2025-2030)
5 Ischemia Reperfusion Injury Breakdown Data by Application
5.1 Global Ischemia Reperfusion Injury Historic Market Size by Application (2019-2024)
5.2 Global Ischemia Reperfusion Injury Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Ischemia Reperfusion Injury Market Size (2019-2030)
6.2 North America Ischemia Reperfusion Injury Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Ischemia Reperfusion Injury Market Size by Country (2019-2024)
6.4 North America Ischemia Reperfusion Injury Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ischemia Reperfusion Injury Market Size (2019-2030)
7.2 Europe Ischemia Reperfusion Injury Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Ischemia Reperfusion Injury Market Size by Country (2019-2024)
7.4 Europe Ischemia Reperfusion Injury Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ischemia Reperfusion Injury Market Size (2019-2030)
8.2 Asia-Pacific Ischemia Reperfusion Injury Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Ischemia Reperfusion Injury Market Size by Region (2019-2024)
8.4 Asia-Pacific Ischemia Reperfusion Injury Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ischemia Reperfusion Injury Market Size (2019-2030)
9.2 Latin America Ischemia Reperfusion Injury Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Ischemia Reperfusion Injury Market Size by Country (2019-2024)
9.4 Latin America Ischemia Reperfusion Injury Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ischemia Reperfusion Injury Market Size (2019-2030)
10.2 Middle East & Africa Ischemia Reperfusion Injury Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2019-2024)
10.4 Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Angion Biomedica
11.1.1 Angion Biomedica Company Detail
11.1.2 Angion Biomedica Business Overview
11.1.3 Angion Biomedica Ischemia Reperfusion Injury Introduction
11.1.4 Angion Biomedica Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.1.5 Angion Biomedica Recent Development
11.2 Catalyst Biosciences
11.2.1 Catalyst Biosciences Company Detail
11.2.2 Catalyst Biosciences Business Overview
11.2.3 Catalyst Biosciences Ischemia Reperfusion Injury Introduction
11.2.4 Catalyst Biosciences Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.2.5 Catalyst Biosciences Recent Development
11.3 Ischemix Inc
11.3.1 Ischemix Inc Company Detail
11.3.2 Ischemix Inc Business Overview
11.3.3 Ischemix Inc Ischemia Reperfusion Injury Introduction
11.3.4 Ischemix Inc Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.3.5 Ischemix Inc Recent Development
11.4 Opsona Therapeutics
11.4.1 Opsona Therapeutics Company Detail
11.4.2 Opsona Therapeutics Business Overview
11.4.3 Opsona Therapeutics Ischemia Reperfusion Injury Introduction
11.4.4 Opsona Therapeutics Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.4.5 Opsona Therapeutics Recent Development
11.5 Pharming
11.5.1 Pharming Company Detail
11.5.2 Pharming Business Overview
11.5.3 Pharming Ischemia Reperfusion Injury Introduction
11.5.4 Pharming Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.5.5 Pharming Recent Development
11.6 TheraSource
11.6.1 TheraSource Company Detail
11.6.2 TheraSource Business Overview
11.6.3 TheraSource Ischemia Reperfusion Injury Introduction
11.6.4 TheraSource Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.6.5 TheraSource Recent Development
11.7 Bolder Biotechnology
11.7.1 Bolder Biotechnology Company Detail
11.7.2 Bolder Biotechnology Business Overview
11.7.3 Bolder Biotechnology Ischemia Reperfusion Injury Introduction
11.7.4 Bolder Biotechnology Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.7.5 Bolder Biotechnology Recent Development
11.8 Corline Biomedical
11.8.1 Corline Biomedical Company Detail
11.8.2 Corline Biomedical Business Overview
11.8.3 Corline Biomedical Ischemia Reperfusion Injury Introduction
11.8.4 Corline Biomedical Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.8.5 Corline Biomedical Recent Development
11.9 Mifcortx
11.9.1 Mifcortx Company Detail
11.9.2 Mifcortx Business Overview
11.9.3 Mifcortx Ischemia Reperfusion Injury Introduction
11.9.4 Mifcortx Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.9.5 Mifcortx Recent Development
11.10 Balmes Transplantation
11.10.1 Balmes Transplantation Company Detail
11.10.2 Balmes Transplantation Business Overview
11.10.3 Balmes Transplantation Ischemia Reperfusion Injury Introduction
11.10.4 Balmes Transplantation Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.10.5 Balmes Transplantation Recent Development
11.11 NovelMed Therapeutics
11.11.1 NovelMed Therapeutics Company Detail
11.11.2 NovelMed Therapeutics Business Overview
11.11.3 NovelMed Therapeutics Ischemia Reperfusion Injury Introduction
11.11.4 NovelMed Therapeutics Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.11.5 NovelMed Therapeutics Recent Development
11.12 Hope Pharmaceuticals
11.12.1 Hope Pharmaceuticals Company Detail
11.12.2 Hope Pharmaceuticals Business Overview
11.12.3 Hope Pharmaceuticals Ischemia Reperfusion Injury Introduction
11.12.4 Hope Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.12.5 Hope Pharmaceuticals Recent Development
11.13 Omeros Corp
11.13.1 Omeros Corp Company Detail
11.13.2 Omeros Corp Business Overview
11.13.3 Omeros Corp Ischemia Reperfusion Injury Introduction
11.13.4 Omeros Corp Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.13.5 Omeros Corp Recent Development
11.14 Prothix
11.14.1 Prothix Company Detail
11.14.2 Prothix Business Overview
11.14.3 Prothix Ischemia Reperfusion Injury Introduction
11.14.4 Prothix Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.14.5 Prothix Recent Development
11.15 SBI Pharmaceuticals
11.15.1 SBI Pharmaceuticals Company Detail
11.15.2 SBI Pharmaceuticals Business Overview
11.15.3 SBI Pharmaceuticals Ischemia Reperfusion Injury Introduction
11.15.4 SBI Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.15.5 SBI Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Ischemia Reperfusion Injury Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Phase 1
Table 3. Key Players of Phase 2
Table 4. Key Players of Preclinical
Table 5. Global Ischemia Reperfusion Injury Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Ischemia Reperfusion Injury Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Ischemia Reperfusion Injury Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Ischemia Reperfusion Injury Market Share by Region (2019-2024)
Table 9. Global Ischemia Reperfusion Injury Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Ischemia Reperfusion Injury Market Share by Region (2025-2030)
Table 11. Ischemia Reperfusion Injury Market Trends
Table 12. Ischemia Reperfusion Injury Market Drivers
Table 13. Ischemia Reperfusion Injury Market Challenges
Table 14. Ischemia Reperfusion Injury Market Restraints
Table 15. Global Ischemia Reperfusion Injury Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Ischemia Reperfusion Injury Market Share by Players (2019-2024)
Table 17. Global Top Ischemia Reperfusion Injury Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ischemia Reperfusion Injury as of 2023)
Table 18. Ranking of Global Top Ischemia Reperfusion Injury Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Ischemia Reperfusion Injury Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Ischemia Reperfusion Injury Product Solution and Service
Table 22. Date of Enter into Ischemia Reperfusion Injury Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Ischemia Reperfusion Injury Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Ischemia Reperfusion Injury Revenue Market Share by Type (2019-2024)
Table 26. Global Ischemia Reperfusion Injury Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Ischemia Reperfusion Injury Revenue Market Share by Type (2025-2030)
Table 28. Global Ischemia Reperfusion Injury Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Ischemia Reperfusion Injury Revenue Market Share by Application (2019-2024)
Table 30. Global Ischemia Reperfusion Injury Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Ischemia Reperfusion Injury Revenue Market Share by Application (2025-2030)
Table 32. North America Ischemia Reperfusion Injury Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Ischemia Reperfusion Injury Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Ischemia Reperfusion Injury Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Ischemia Reperfusion Injury Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Ischemia Reperfusion Injury Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Ischemia Reperfusion Injury Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Ischemia Reperfusion Injury Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Ischemia Reperfusion Injury Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Ischemia Reperfusion Injury Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Ischemia Reperfusion Injury Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Ischemia Reperfusion Injury Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Ischemia Reperfusion Injury Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Ischemia Reperfusion Injury Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2025-2030) & (US$ Million)
Table 47. Angion Biomedica Company Detail
Table 48. Angion Biomedica Business Overview
Table 49. Angion Biomedica Ischemia Reperfusion Injury Product
Table 50. Angion Biomedica Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 51. Angion Biomedica Recent Development
Table 52. Catalyst Biosciences Company Detail
Table 53. Catalyst Biosciences Business Overview
Table 54. Catalyst Biosciences Ischemia Reperfusion Injury Product
Table 55. Catalyst Biosciences Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 56. Catalyst Biosciences Recent Development
Table 57. Ischemix Inc Company Detail
Table 58. Ischemix Inc Business Overview
Table 59. Ischemix Inc Ischemia Reperfusion Injury Product
Table 60. Ischemix Inc Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 61. Ischemix Inc Recent Development
Table 62. Opsona Therapeutics Company Detail
Table 63. Opsona Therapeutics Business Overview
Table 64. Opsona Therapeutics Ischemia Reperfusion Injury Product
Table 65. Opsona Therapeutics Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 66. Opsona Therapeutics Recent Development
Table 67. Pharming Company Detail
Table 68. Pharming Business Overview
Table 69. Pharming Ischemia Reperfusion Injury Product
Table 70. Pharming Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 71. Pharming Recent Development
Table 72. TheraSource Company Detail
Table 73. TheraSource Business Overview
Table 74. TheraSource Ischemia Reperfusion Injury Product
Table 75. TheraSource Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 76. TheraSource Recent Development
Table 77. Bolder Biotechnology Company Detail
Table 78. Bolder Biotechnology Business Overview
Table 79. Bolder Biotechnology Ischemia Reperfusion Injury Product
Table 80. Bolder Biotechnology Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 81. Bolder Biotechnology Recent Development
Table 82. Corline Biomedical Company Detail
Table 83. Corline Biomedical Business Overview
Table 84. Corline Biomedical Ischemia Reperfusion Injury Product
Table 85. Corline Biomedical Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 86. Corline Biomedical Recent Development
Table 87. Mifcortx Company Detail
Table 88. Mifcortx Business Overview
Table 89. Mifcortx Ischemia Reperfusion Injury Product
Table 90. Mifcortx Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 91. Mifcortx Recent Development
Table 92. Balmes Transplantation Company Detail
Table 93. Balmes Transplantation Business Overview
Table 94. Balmes Transplantation Ischemia Reperfusion Injury Product
Table 95. Balmes Transplantation Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 96. Balmes Transplantation Recent Development
Table 97. NovelMed Therapeutics Company Detail
Table 98. NovelMed Therapeutics Business Overview
Table 99. NovelMed Therapeutics Ischemia Reperfusion Injury Product
Table 100. NovelMed Therapeutics Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 101. NovelMed Therapeutics Recent Development
Table 102. Hope Pharmaceuticals Company Detail
Table 103. Hope Pharmaceuticals Business Overview
Table 104. Hope Pharmaceuticals Ischemia Reperfusion Injury Product
Table 105. Hope Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 106. Hope Pharmaceuticals Recent Development
Table 107. Omeros Corp Company Detail
Table 108. Omeros Corp Business Overview
Table 109. Omeros Corp Ischemia Reperfusion Injury Product
Table 110. Omeros Corp Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 111. Omeros Corp Recent Development
Table 112. Prothix Company Detail
Table 113. Prothix Business Overview
Table 114. Prothix Ischemia Reperfusion Injury Product
Table 115. Prothix Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 116. Prothix Recent Development
Table 117. SBI Pharmaceuticals Company Detail
Table 118. SBI Pharmaceuticals Business Overview
Table 119. SBI Pharmaceuticals Ischemia Reperfusion Injury Product
Table 120. SBI Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 121. SBI Pharmaceuticals Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ischemia Reperfusion Injury Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Ischemia Reperfusion Injury Market Share by Type: 2023 VS 2030
Figure 3. Phase 1 Features
Figure 4. Phase 2 Features
Figure 5. Preclinical Features
Figure 6. Global Ischemia Reperfusion Injury Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Ischemia Reperfusion Injury Market Share by Application: 2023 VS 2030
Figure 8. Heart Injury Case Studies
Figure 9. Kidney Injury Case Studies
Figure 10. Intestine Injury Case Studies
Figure 11. Other Injury Case Studies
Figure 12. Ischemia Reperfusion Injury Report Years Considered
Figure 13. Global Ischemia Reperfusion Injury Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Ischemia Reperfusion Injury Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Ischemia Reperfusion Injury Market Share by Region: 2023 VS 2030
Figure 16. Global Ischemia Reperfusion Injury Market Share by Players in 2023
Figure 17. Global Top Ischemia Reperfusion Injury Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ischemia Reperfusion Injury as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Ischemia Reperfusion Injury Revenue in 2023
Figure 19. North America Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Ischemia Reperfusion Injury Market Share by Country (2019-2030)
Figure 21. United States Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Ischemia Reperfusion Injury Market Share by Country (2019-2030)
Figure 25. Germany Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Ischemia Reperfusion Injury Market Share by Region (2019-2030)
Figure 33. China Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Ischemia Reperfusion Injury Market Share by Country (2019-2030)
Figure 41. Mexico Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Ischemia Reperfusion Injury Market Share by Country (2019-2030)
Figure 45. Turkey Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Angion Biomedica Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)
Figure 48. Catalyst Biosciences Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)
Figure 49. Ischemix Inc Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)
Figure 50. Opsona Therapeutics Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)
Figure 51. Pharming Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)
Figure 52. TheraSource Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)
Figure 53. Bolder Biotechnology Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)
Figure 54. Corline Biomedical Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)
Figure 55. Mifcortx Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)
Figure 56. Balmes Transplantation Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)
Figure 57. NovelMed Therapeutics Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)
Figure 58. Hope Pharmaceuticals Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)
Figure 59. Omeros Corp Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)
Figure 60. Prothix Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)
Figure 61. SBI Pharmaceuticals Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
